Home/Filings/4/0001628280-25-016481
4//SEC Filing

Mandel-Brehm Josh 4

Accession 0001628280-25-016481

CIK 0001736730other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:06 PM ET

Size

5.5 KB

Accession

0001628280-25-016481

Insider Transaction Report

Form 4
Period: 2025-04-01
Mandel-Brehm Josh
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-01+160,000160,000 total
    Exercise: $3.86Exp: 2035-03-31Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant.

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

Entity typeother

Related Parties

1
  • filerCIK 0001927058

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:06 PM ET
Size
5.5 KB